The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review

被引:34
|
作者
Non, Lemuel R. [1 ]
Santos, Carlos A. Q. [2 ]
机构
[1] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[2] Rush Univ, Med Ctr, Div Infect Dis, Chicago, IL 60612 USA
关键词
Staphylococcus lugdunensis; Endocarditis; Bacteremia; SCORING SYSTEMS; RISK-FACTORS; MORTALITY; IDENTIFICATION; MULTICENTER; PREDICTION; SEPSIS; IMPACT;
D O I
10.1016/j.jinf.2016.10.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Staphylococcus lugdunensis is a coagulase-negative staphylococcus with similar virulence characteristics as Staphylococcus aureus. Whether S. lugdunensis causes infective endocarditis (IE) in a similar proportion of cases as S. aureus (reported to be 12.6% in a definitive multicenter prospective study) is unclear. Methods: We conducted a retrospective cohort study of adult patients with at least one blood culture positive for S. lugdunensis at our institution from January 2006 to December 2014. We examined microbiology data, ascertained disease severity and determined the proportion of patients with definite or possible IE based on the 2000 Modified Duke Criteria. Because coagulase-negative staphylococci were routinely identified to the species level at our institution from 2012 onwards, we determined the proportion of patients with definite or possible IE before and after implementation of routine speciation. We also compared our results with reported proportions of IE among patients with S. lugdunensis bacteremia (SLB) in other institutions by conducting a systematic review of the scientific literature. Nonparametric bootstrapping methods were performed to determine 95% confidence intervals (CI) for proportions of IE in patients with SLB. Results: Seventy-four patients with SLB were identified, of whom 64% (47/74) had sepsis by SIRS criteria, and 18% (13/74) had severe illness by Pittsburgh bacteremia score (PBS). KaplaneMeier survival analysis showed that one-year survival among patients with severe illness was worse than patients with non-severe illness (p=0.02). Fifteen percent (11/74) of patients had definite or possible IE (95% CI 6.8-23.0%). The proportion of SLB patients with definite or possible IE was 15.8% (6/38, 95% CI 5.3-28.9%) prior to routine speciation and 13.9% (5/36, 95% CI 2.8-27.8%) after routine speciation (p = 0.71). Among patients with at least two positive blood cultures for S. lugdunensis, 25% (10/40, 95% CI 12.5-40.0%) had IE. Systematic review of the literature yielded eight relevant retrospective studies. Of studies that included patients with one or more positive blood cultures for S. lugdunensis, the proportion of IE ranged from 6.3% to 27.0%. Conclusion: The proportion of definite or possible IE among patients with SLB is similar to the proportion of IE among patients with S. aureus bacteremia. The proportions of IE among patients with SLB at other institutions fall within the 95% CI yielded by bootstrapping. Our findings suggest that growth of S. lugdunensis in two separate blood cultures should prompt consideration of workup for IE. (C) 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 50 条
  • [21] Mitral valve repair for Staphylococcus lugdunensis infective endocarditis: report of a case
    Ishida, Narihiro
    Shimabukuro, Katsuya
    Matsuno, Yukihiro
    Higashi, Toshiya
    Takemura, Hirofumi
    SURGERY TODAY, 2014, 44 (10) : 1946 - 1948
  • [22] Mitral valve repair for Staphylococcus lugdunensis infective endocarditis: report of a case
    Narihiro Ishida
    Katsuya Shimabukuro
    Yukihiro Matsuno
    Toshiya Higashi
    Hirofumi Takemura
    Surgery Today, 2014, 44 : 1946 - 1948
  • [23] Gerbode Defect with Staphylococcus lugdunensis Native Tricuspid Valve Infective Endocarditis
    Carpenter, Robert J.
    Price, Gregory D.
    Boswell, Gilbert E.
    Nayak, Keshav R.
    Ramirez, Alfredo R.
    JOURNAL OF CARDIAC SURGERY, 2012, 27 (03) : 316 - 320
  • [24] Comparison of Staphylococcus lugdunensis and staphylococcus epidermidis native valve endocarditis from the International Collaboration on Endocarditis - Prospective cohort study
    Chu, V. H.
    Woods, C. W.
    Miro, J. M.
    Hoen, B.
    Cabell, C. H.
    Pappas, P. A.
    Athan, E.
    Barsic, B.
    Bouza, E.
    Braun, S.
    Korman, T.
    Murdoch, D. R.
    Tripodi, M.-F.
    Corey, G. R.
    Fowler, V. G., Jr.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (06) : 420 - 420
  • [25] STAPHYLOCOCCUS LUGDUNENSIS: A RARE BUT DESTRUCTIVE CAUSE OF INFECTIVE ENDOCARDITIS WITH ECHOCARDIOGRAPHIC AND CLINICAL FEATURES SIMILAR TO STAPHYLOCCOCCUS AUREUS INFECTIVE ENDOCARDITIS
    Sabe, Marwa
    Shrestha, Nabin
    Gordon, Steven
    Menon, Venu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E2030 - E2030
  • [26] Staphylococcus Lugdunensis Tricuspid Valve Infective Endocarditis Complicated By Septic Pulmonary Embolism
    Gardiner, R.
    Bolster, F.
    Walsh, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S32 - S32
  • [27] Maternal Bacteremia Caused by Staphylococcus Aureus With a Focus on Infective Endocarditis
    Morelli, Morgan K.
    Veve, Michael P.
    Shorman, Mahmoud A.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (08):
  • [28] Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia
    Salvador, Vincent Bryan D.
    Chapagain, Bikash
    Joshi, Astha
    Brennessel, Debra J.
    TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (01): : 10 - 15
  • [29] Time to Staphylococcus aureus Blood Culture Positivity as a Risk Marker of Infective Endocarditis: A Retrospective Cohort Study
    Stromdahl, Martin
    Hagman, Karl
    Hedman, Karolina
    Westman, Anna
    Hedenstierna, Magnus
    Ursing, Johan
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [30] Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study
    Aldman, Malin Hagstrand
    Rasmussen, Magnus
    Olaison, Lars
    Pahlman, Lisa I.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 1103 - 1106